| The assessment of disability related to vision performance-based measure in diabetic retinopathy. | |
| | |
MedLine Citation:
|
PMID: 20399929 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: To validate a third-generation performance-based measure of visual function titled "Assessment of Disability Related to Vision" (ADREV) in a study population of patients with diabetic retinopathy. DESIGN: Prospective, cross-sectional study. METHODS: Patients with nonproliferative or proliferative diabetic retinopathy, free from ocular comorbidity, were recruited from a single institute and completed the ADREV, the 25-Item National Eye Institute Visual Functioning Questionnaire (VFQ-25), and a clinical ophthalmic examination. Correlation, regression, and bootstrap analysis were conducted to determine the relationship between ADREV scoring and each of the study's clinical and self-report measures of visual ability, while controlling for potential confounders. RESULTS: Ninety-one patients with diabetic retinopathy completed the study and analysis showed that the ADREV total and subscale scores shared a stronger relationship with the clinical measures of visual function than did the VFQ total and subscale scores. Regression analysis revealed that binocular visual acuity, contrast sensitivity, and better eye visual field were the best predictors of ADREV performance. CONCLUSIONS: The ADREV performance measure is a valid instrument for the assessment of disability related to vision in patients with diabetic retinopathy. Furthermore, the assessments provided by ADREV were more related to traditional clinical indicators of visual impairment than were the results of the self-report measure, specifically the VFQ-25. |
| | |
Authors:
|
Kevin J Warrian; Luciano L Lorenzana; Dara Lankaranian; Jyoti Dugar; Sheryl S Wizov; George L Spaeth |
Related Documents
:
|
8638169 - Diabetic eye disease: a primary care perspective. 3790479 - Ophthalmic survey of a diabetic clinic. i: ocular findings. 6662009 - Narrowing of the palpebral fissure in diabetes. 10664939 - Correlation between glycemic control and menstruation in diabetic adolescents. 9157089 - An association in non-insulin-dependent diabetes mellitus subjects between susceptibili... 1779019 - Factors associated with diabetic microangiopathy: a study of 157 type i (insulin-depend... 19788429 - Insulin use and increased risk of mortality in type 2 diabetes: a cohort study. 1377809 - Staining of semithin tissue sections embedded in hpma, quetol 523 and mma. 12018409 - Isosteric replacement of a3 val of porcine insulin by allo-thr. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Validation Studies |
Journal Detail:
|
Title: American journal of ophthalmology Volume: 149 ISSN: 1879-1891 ISO Abbreviation: Am. J. Ophthalmol. Publication Date: 2010 May |
Date Detail:
|
Created Date: 2010-04-19 Completed Date: 2010-05-06 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0370500 Medline TA: Am J Ophthalmol Country: United States |
Other Details:
|
Languages: eng Pagination: 852-60.e1 Citation Subset: AIM; IM |
Copyright Information:
|
Copyright 2010 Elsevier Inc. All rights reserved. |
Affiliation:
|
Glaucoma Research Center, William and Anna Goldberg Glaucoma Service, Wills Eye Institute, Philadelphia, Pennsylvania, USA. kevinjwarrian@gmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Comorbidity Contrast Sensitivity / physiology Cross-Sectional Studies Diabetic Retinopathy / diagnosis* Disability Evaluation* Female Humans Male Middle Aged Prospective Studies Quality of Life Questionnaires Sickness Impact Profile* Vision Disorders / diagnosis* Vision, Binocular / physiology Visual Acuity / physiology Visually Impaired Persons* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Estrogen receptor beta gene polymorphism and intraocular pressure elevation in female patients with ...
Next Document: Endothelial dysfunction: role of vasodilating betablockers in hypertension and chronic heart failure